M Dukeman

675 total citations
8 papers, 513 citations indexed

About

M Dukeman is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, M Dukeman has authored 8 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in M Dukeman's work include Lung Cancer Treatments and Mutations (5 papers), Neuroendocrine Tumor Research Advances (3 papers) and Lung Cancer Research Studies (3 papers). M Dukeman is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Neuroendocrine Tumor Research Advances (3 papers) and Lung Cancer Research Studies (3 papers). M Dukeman collaborates with scholars based in United States. M Dukeman's co-authors include David P. Kelsen, David W. Braun, Robert B. Golbey, Ephraim S. Casper, Charles W. Young, Nael Martini, Richard J. Gralla, Manjit S. Bains, Robert Chapman and Robert T. Heelan and has published in prestigious journals such as Annals of Internal Medicine, Cancer and The American Journal of Medicine.

In The Last Decade

M Dukeman

8 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Dukeman United States	7	360	252	224	99	74	8	513
Hans Günter Derigs Germany	5	518 1.4×	361 1.4×	256 1.1×	57 0.6×	64 0.9×	5	677
Pratt Cb United States	12	208 0.6×	157 0.6×	88 0.4×	60 0.6×	130 1.8×	20	509
Douglass Ho United States	13	335 0.9×	225 0.9×	230 1.0×	59 0.6×	41 0.6×	33	555
Sunmolu Beckley United States	12	204 0.6×	79 0.3×	164 0.7×	54 0.5×	39 0.5×	14	398
Maria Koumpou Greece	8	126 0.3×	139 0.6×	146 0.7×	68 0.7×	26 0.4×	12	321
Vogelzang Nj United States	9	114 0.3×	106 0.4×	248 1.1×	103 1.0×	30 0.4×	12	436
Christopher A. Sattler United States	9	204 0.6×	188 0.7×	138 0.6×	62 0.6×	101 1.4×	14	411
Edward Rosenblatt Israel	12	133 0.4×	219 0.9×	198 0.9×	26 0.3×	89 1.2×	20	494
Esra Kaytan Türkiye	10	189 0.5×	240 1.0×	174 0.8×	46 0.5×	115 1.6×	18	480
Kenneth M. Griffith United States	7	190 0.5×	185 0.7×	78 0.3×	144 1.5×	76 1.0×	11	475

Countries citing papers authored by M Dukeman

Since Specialization

Citations

This map shows the geographic impact of M Dukeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Dukeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Dukeman more than expected).

Fields of papers citing papers by M Dukeman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Dukeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Dukeman. The network helps show where M Dukeman may publish in the future.

Co-authorship network of co-authors of M Dukeman

This figure shows the co-authorship network connecting the top 25 collaborators of M Dukeman. A scholar is included among the top collaborators of M Dukeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Dukeman. M Dukeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Sternberg, C., D. P. Kelsen, M Dukeman, Lawrence Leichman, & R T Heelan. (1985). Carboplatin: a new platinum analog in the treatment of epidermoid carcinoma of the esophagus.. PubMed. 69(11). 1305–7. 26 indexed citations

2.

Bosl, George J., Alan Yagoda, Willet F. Whitmore, et al.. (1984). VP-16–213 and cisplatin in the treatment of patients with refractory germ cell tumors. American Journal of Clinical Oncology. 7(4). 327–330. 28 indexed citations

3.

Bains, Manjit S., et al.. (1983). Phase II study of etoposide in the treatment of esophageal carcinoma.. PubMed. 67(4). 397–8. 15 indexed citations

4.

Kelsen, David P., Basil S. Hilaris, Craig J. Coonley, et al.. (1983). Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma. The American Journal of Medicine. 75(4). 645–652. 90 indexed citations

5.

Cheng, Edgar, et al.. (1983). Phase II trial of etoposide in adenocarcinomas of the upper gastrointestinal tract.. PubMed. 67(5). 509–10. 8 indexed citations

6.

Kelsen, David P., Robert Chapman, Manjit S. Bains, et al.. (1982). Phase II study of methyl-GAG in the treatment of esophageal carcinoma.. PubMed. 66(6). 1427–9. 6 indexed citations

7.

Gralla, Richard J., Ephraim S. Casper, David P. Kelsen, et al.. (1981). Cisplatin and Vindesine Combination Chemotherapy for Advanced Carcinoma of the Lung: A Randomized Trial Investigating Two Dosage Schedules. Annals of Internal Medicine. 95(4). 414–420. 283 indexed citations

8.

Reynolds, Thomas F., Davor Vugrin, Esteban Cvitkovic, et al.. (1981). VAB-3 combination chemotherapy of metastatic testicular cancer. Cancer. 48(4). 888–898. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact